# Piotr Tomczak

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/piotr-tomczak/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,298 |
| Field | Renal cell carcinoma treatment |
| h-index | 42 |
| i10-index | 88 |
| Last Known Institution | Poznan University of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5082009347 |
| ORCID iD | https://orcid.org/0000-0002-8816-5525 |
| Works | 201 |

## Researcher papers

- [Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/temsirolimus-interferon-alfa-or-both-for-advanced-renal-cell-carcinoma/)
- [Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-placebo-as-post-nephrectomy-adjuvant-therapy-for-clear-cell/)
- [Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-cabozantinib-versus-cabozantinib-monotherapy-for-patients-with/)

## Researcher topics

- [Theoretical and Computational Physics](https://scholariq.org/topics/theoretical-and-computational-physics/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Poznan University of Medical Sciences](https://scholariq.org/institutions/poznan-university-of-medical-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.